3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
55
Colonic Neoplasms
22
Adenoma
16
Colonic Polyps
13
Polyps
7
Colorectal Neoplasms, Hereditary Nonpolyposis
6
Neoplasms
5
Adenomatous Polyps
5
Rectal Neoplasms
4
Pain
4
Disease
4
Colitis, Ulcerative
2
Anus Neoplasms
2
Adenomatous Polyposis Coli
2
Turcot syndrome
1
Recurrence
1
Personal Satisfaction
1
Patient Satisfaction
1
Pathologic Complete Response
1
Lymphoma, Mantle-Cell
1
Li-Fraumeni Syndrome
1
Irritable Bowel Syndrome
1
Intestinal Neoplasms
1
Inflammatory Bowel Diseases
1
Hyperplasia
1
Hamartoma Syndrome, Multiple
1
HIV Infections
1
Gastrointestinal Neoplasms
1
Diverticulitis, Colonic
1
Diverticulitis
1
Interventions
pembrolizumab
10
Nivolumab
9
Ipilimumab
4
avelumab
3
Neoadjuvant Therapy
3
toripalimab
2
sintilimab
2
durvalumab
2
atezolizumab
2
Specimen Handling
2
Immune Checkpoint Inhibitors
2
Celecoxib
2
tislelizumab
1
spartalizumab
1
relatlimab
1
regorafenib
1
fludarabine phosphate
1
fludarabine
1
dostarlimab
1
denileukin diftitox
1
danvatirsen
1
camrelizumab
1
XELOX
1
Taxes
1
Surgical Procedures, Operative
1
Radiation Dose Hypofractionation
1
Paclitaxel
1
Oxaliplatin
1
Megestrol Acetate
1
Medroxyprogesterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Turcot syndrome
×
Colonoscopy
×
Clear all
NCT07360834
2026-01-23
PREDI-LYNCH
UNICANCER
Phase NA
Not yet recruiting
2,000 enrolled